J9202
HCPCSGoserelin acetate implant
Official HCPCS Level II long descriptor
Goserelin acetate implant, per 3.6 mg
HCPCS Level II code J9202 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Goserelin acetate implant
Added to HCPCS: 1991-01-01
Nearby codes in J9
- J9183Gemcitabine intravesical sys
- J9184Inj gemcitabin (avyxa) 200mg
- J9185Fludarabine phosphate inj
- J9190Fluorouracil injection
- J9196Inj gemcitabine hcl (accord)
- J9198Inj. infugem, 100 mg
- J9200Floxuridine injection
- J9201In gemcitabine hcl nos 200mg
- J9203Gemtuzumab ozogamicin 0.1 mg
- J9204Inj mogamulizumab-kpkc, 1 mg
- J9205Inj irinotecan liposome 1 mg
- J9206Irinotecan injection
- J9207Ixabepilone injection
- J9208Ifosfamide injection
- J9209Mesna injection
- J9210Inj., emapalumab-lzsg, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.